EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Bioequivalence study of 400 and 100 mg imatinib film-coated tablets in healthy volunteers


, : Bioequivalence study of 400 and 100 mg imatinib film-coated tablets in healthy volunteers. Acta Poloniae Pharmaceutica 71(5): 843-854

The aim of the study was to investigate the bioavailability of a generic product of 100 mg and 400 mg imatinib film-coated tablets (test) as compared to that of a branded product (reference) at the same strength to determine bioequivalence. The secondary objective of the study was to evaluate tolerability of both products. An open-label, randomized, crossover, two-period, single-dose, comparative study was conducted in 43 (Imatynib-Biofarm 100 mg film-coated tablet) and in 42 (Imatynib-Biofarm 400 mg film-coated tablet), brand name Imatenil, Caucasian healthy volunteers in fed conditions. A single oral dose administration of the test or reference product was separated by 14-day washout period. The imatinib and its metabolite N-desmethyl imatinib concentrations were determined using a validated LC MS/MS method. The results of the single-dose study in healthy volunteers indicated that the film-coated tablets of Imatynib-Biofarm 100 mg and 400 mg film-coated tablets manufactured by Biofarm Sp. z o.o. (test products) are bioequivalent to those of Glivec 100 mg and 400 mg film-coated tablets manufactured by Novartis Pharma GmbH (reference products). Both products in the two doses of imatinib were well tolerated.


Accession: 051805357

PMID: 25362813

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Buś-Kwaśnik, K.; Rudzki, P.J.; Ksycińska, H.; Leś, A.; Serafin-Byczak, K.; Raszek, J.; Bielak, A.; Wybraniec, A.; Płatek, A.E.; Szymanski, F.M.; Łazowski, T., 2016: Bioequivalence study of 2.5 mg film-coated bisoprolol tablets in healthy volunteers. Bisoprolol is one of the most widely used β-blockers characterized by cardioselectivity and has no intrinsic sympathomimetic activity (ISA). It is commonly used in the treatment of coronary heart disease or heart failure. The aim of study was to...

Rudzki, P.J.; Kaza, M.; Leś, A.; Gilant, E.; Ksycińska, H.; Serafin-Byczak, K.; Troć, M.; Raszek, J.; Piątkowska-Chabuda, E.; Skowrońska-Smolak, M.; Tarasiuk, A.; Wilkowska, E.; Łazowski, T., 2014: Bioequivalence study of 8 mg ondansetron film-coated tablets in healthy Caucasian volunteers. The aim of the study was to investigate the bioequivalence of a generic product of 8 mg film-coated tablets (test) to the branded product (reference) at the same strength in order to apply for regulatory approval. The secondary objective of the...

Kaza, Mł.; Leś, A.; Serafin-Byczak, K.; Ksycińska, H.; Rudzki, P.J.; Gutkowskpi, P.; Drewniak, T.; Gutkowska, A.; Tarasiuk, A.; Piatkowska-Chabuda, E.; Skowrońska-Smolak, Młgorzata.; Wilkowska, E., 2013: Bioequivalence study of 500 mg cefuroxime axetil film-coated tablets in healthy volunteers. The aim of the study was to investigate the bioavailability of a generic product of 500 mg cefuroxime axetil film-coated tablets (test) as compared to that of a branded product (reference) at the same strength to determine bioequivalence and to ap...

Parrillo-Campiglia, S.; Ercoli, Mónica.Cedres.; Umpierrez, O.; Rodríguez, P.; Márquez, S.; Guarneri, C.; Estevez-Parrillo, F.T.; Laurenz, M.; Estevez-Carrizo, F.E., 2010: Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers. Imatinib is a tyrosine kinase inhibitor that has been established as a highly effective therapy for chronic myelogenous leukemia and gastrointestinal stromal tumors. A new generic, once-daily 400-mg tablet of imatinib has been developed by a pharm...

Pedroso, P.; Almeida, S.; Filipe, A.; Neves, R.I.; Boudreault, S.; Jiménez, C., 2013: Bioequivalence studies for two different strengths of montelukast in healthy volunteers: 10 mg film-coated tablets and 5 mg chewable tablets. In order to assess the bioequivalence of 2 different formulations of montelukast, a pivotal trial for the montelukast 10 mg film-coated tablets formulation and a pivotal trial for the montelukast 5 mg chewable tablets formulation were conducted.Fo...

Filipe, A.; Pedroso, P.; Almeida, S.; Neves, R.; Boudreault, S., 2015: Bioequivalence study of two formulations of ibandronic acid 150-mg film-coated tablets in healthy volunteers under fasting conditions: a randomized, open-label, three-way, reference-replicated crossover study. This bioequivalence study aimed to compare rate and extent of absorption of a generic medicinal product of ibandronic acid 150-mg film-coated tablet versus Bonviva(®). This was a single-centre, open-label, randomized, three-way, three-sequence, r...

Cánovas, M.; Cabré, F.; Polonio, F., 2014: Bioequivalence studies for 2 different strengths of irbesartan/hydrochlorothiazide combination in healthy volunteers: 300/25 mg and 300/12.5 mg film-coated tablets. Two bioequivalence studies of irbesartan (CAS 138402-11-6) and hydrochlorothiazide (CAS 58-93-5) combination at 300/12.5 mg and 300/25 mg strengths were carried out in order to assess the bioequivalence of these film-coated tablet formulations...

Bus-Kwasnik, K.; Ksycinska, H.; Les, A.; Serafin-Byczak, K.; Rudzki, P.J.; Raszek, J.; Lazowski, T.; Bielak, A.; Wybraniec, A., 2013: Bioequivalence and pharmacokinetics of two 10-mg bisoprolol formulations as film-coated tablets in healthy white volunteers: a randomized, crossover, open-label, 2-period, single-dose, fasting study. The aim of the study was to investigate the bioavailability of a generic formulation of 10-mg bisoprolol film coated tablets (test) as compared to that of a branded formulation (reference) at the same strength to determine bioequivalence and to ap...

Bittner, B.; Riek, M.; Holmes, B.; Grange, S., 2005: Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers. To establish the bioequivalence of a 500 mg film-coated tablet of saquinavir mesylate (FCT SQV) to the 200 mg hard-capsule saquinavir mesylate (HC SQV), both boosted with ritonavir and administered under fed conditions. We carried out a multi-cent...

V.V.Smirnov, O.A.Tashirova, M.R.Khaitov, 2013: Comparative pharmacokinetics and bioequivalence of two imatinib formulations as film-coated tablets, 400 mg. The comparative pharmacokinetics and bioequivalence of imatinib formulations, as Genfatinib<sup> </sup>, 400-mg film-coated tablets (Tutor Laboratories S.A.S.I.F.I.A., Varifarma Laboratories, S. A., Argentina) (test formulation) and Gl...